EICHOR
● Active Not Recruiting
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
Condition: HIV-1-Infection · Sponsor: Gilead Sciences
About this study
The goal of this clinical study is to learn more about the safety and efficacy of switching to a once weekly tablet of islatravir/lenacapavir (ISL/LEN) regimen versus continuing standard of care treatment in people with human immunodeficiency virus (PWH) who are virologically suppressed (HIV-1 RNA levels \< 50 copies/mL) on a stable standard of care regimen for ≥ 6 months prior to screening. The standard of care includes 2 or 3 medicines, antiretroviral agents (ARVs). The primary objective of the study is to evaluate the efficacy of switching to oral weekly ISL/LEN tablet regimen versus continuing standard of care in virologically suppressed PWH at Week 48.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (100)
| University of Alabama at Birmingham(UAB) 1917 Research Clinic | Birmingham, Alabama, United States | — |
| Pueblo Family Physicians | Phoenix, Arizona, United States | — |
| Vv-Tmf-5366229 | Los Angeles, California, United States | — |
| Ruane Clinical Research Group | Los Angeles, California, United States | — |
| BIOS Clinical Research | Palm Springs, California, United States | — |
| Vivent Health | Denver, Colorado, United States | — |
| University of Colorado Clinical and Translational Research Center | Denver, Colorado, United States | — |
| Yale University; School of Medicine; AIDS Program | New Haven, Connecticut, United States | — |
| Georgetown University Medical Center | Washington D.C., District of Columbia, United States | — |
| Aids Healthcare Foundation - Northpoint | Fort Lauderdale, Florida, United States | — |
| Midway Immunology and Research Center | Ft. Pierce, Florida, United States | — |
| CAN Community Health | Miami Gardens, Florida, United States | — |
+ 88 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06630299